Clinical Trial: NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
Brief Summary:
To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe.Phase 2 will open if the Phase 1 dose is found to be safe.To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate cancer before they have surgery to remove the disease.
Read more